Manuela García López

Title: Manuela García López: Innovator in Neuropathic Pain Treatment

Introduction

Manuela García López is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neuropathic pain. Her innovative work has led to the development of a unique compound that shows promise in alleviating this challenging condition.

Latest Patents

Manuela holds a patent for "Sulphated disaccharides for the treatment of neuropathic pain." This invention relates to sulphated disaccharides of formula (I) that are effective in treating neuropathic pain. The pharmaceutical composition she developed includes the compound of formula (I) along with at least one pharmaceutically acceptable excipient. The compounds have demonstrated effectiveness in various experimental models of neuropathic pain, making them suitable for treating different types of neuropathic pain and their clinical manifestations, such as mechanical allodynia or cold allodynia. She has 1 patent to her name.

Career Highlights

Throughout her career, Manuela has worked with notable organizations, including Bioberica, S.A.U. and Universidad Autónoma de Madrid. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Manuela has collaborated with esteemed colleagues such as Josep Vergés Milano and Eulàlia Montell Bonaventura. These partnerships have enriched her research and expanded the impact of her work in the field.

Conclusion

Manuela García López is a trailblazer in the development of treatments for neuropathic pain, with her innovative patent paving the way for future advancements in this area. Her contributions to pharmaceutical sciences highlight the importance of research and collaboration in addressing complex medical challenges.